Main Menu

Translational Oncogenomics Team

Dr Marco Gerlinger's team investigates the impact of genetic and non-genetic intra-tumour heterogeneity on disease progression and how systemic therapies re-shape cancer genomic landscapes.

Team leader

Dr Marco Gerlinger

Dr Marco Gerlinger

Dr Marco Gerlinger develops new tools to detect and track the evolution of cancer cells within tumours and better therapies which prevent the evolution of drug resistance. He holds an Honorary Consultant Medical Oncologist position at The Royal Marsden NHS Foundation Trust, where he treats patients with gastrointestinal cancers.

ORCID 0000-0003-2719-299X

Team members

Dr Louise Barber

Higher Scientific Officer

Beatrice Griffiths

Higher Scientific Officer

Alice Newey

PhD Student

Maria Semiannikova

PhD Student

Georgia Spain

PhD Student

Dr Andrew Woolston

Postdoctoral Fellow